TNF and infection: The concomitant use of corticosteroids is significantly associated with infection risk; however, the infection risk of biologics such as anti-TNF and JAK inhibitors should be assessed in conjunction with individual patient characteristics [325]; COVID-19 data support that maintenance therapy during the pandemic does not increase the risk of severe illness [326].